ARCHIVES

Britain’s Cancer Czar Begins Examination of Risks and Benefits of Mammography

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

March 31, 2000

Members of Congress say that won’t work.

September 30, 2005

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

Hollings Resolution Recognizes 20th Year Of National Cancer Act

May 3, 1991